Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Southern California
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
HiFiBiO Therapeutics
Seattle Children's Hospital
TScan Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Valo Therapeutics Oy
Adaptimmune